News and analysis of US-traded Chinese and China-related stocks. No buy or sell recommendations. Provided by Seeking Alpha.

Visit SeekingAlpha China Stocks

China Biotech in Review: Deals, Developments and Financials

Posted on September 28, 2008

Stories about new deals, drug development and financial news showed that China biophama continued its evolution last week. Phynova (PHNVY.PK) was a prominent example. The UK-based botanical drug company announced that it has adopted a more China-centric focus (see story). Traditionally, the company has always had a connection to China; it owns a 45% share in Botanic Century Beijing Ltd, a drug development company, and its previous business plan called for the use of TCM formulations as a basis for drugs that addressed unmet medical needs in the west. Now, the company will concentrate its atten...

Original article link


beijing , china , shanghai